LifeMD - רווח למניה אחת ב-12 החודשים האחרונים LFMD

LifeMD, Inc. (LFMD) has established a comprehensive remote treatment cycle, integrating virtual physician visits with express medication delivery. The business targets men and individuals with chronic pathologies, expanding its reach within the US digital healthcare sector via a subscription service. The optimization of pharmacy partnerships minimizes logistical risks, which is confirmed by the price trend on GURU.Markets shown in this chart, where the current EPS TTM stands at -144.00.

LifeMD, Inc. (LFMD) maintains stability through the effective scaling of its telemedicine subscription model while reducing customer acquisition costs. This indicator captures the rolling annual growth of net earnings per share, reflecting margin dynamics after each session. It is critical for investors to evaluate this pace as an indicator of operating leverage to avoid buying at the peak of demand. The current value of -144.00 in the annual EPS TTM delta confirms the profit expansion vector.